Haemonetics's average Accounts Receivable for the
three
months ended in Dec. 2023 was $193 Mil. Haemonetics's Revenue for the
three
months ended in Dec. 2023 was $336 Mil.
Hence, Haemonetics's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 52.36.
The historical rank and industry rank for Haemonetics's Days Sales Outstanding or its related term are showing as below:
HAE'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.72 Med: 61.81 Max: 65.09
Current: 53.06
During the past 13 years, Haemonetics's highest Days Sales Outstanding was 65.09. The lowest was 52.72. And the median was 61.81.
HAE's Days Sales Outstanding is ranked better than 64.31% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 63.7
vs HAE: 53.06
Haemonetics's Days Sales Outstanding
declined
from Dec. 2022 (52.70) to Dec. 2023 (52.36).
Haemonetics Days Sales Outstanding Historical Data
The historical data trend for Haemonetics's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Haemonetics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haemonetics Days Sales Outstanding Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Haemonetics's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Haemonetics's Days Sales Outstanding falls into.
Haemonetics Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haemonetics (NYSE:HAE) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Haemonetics Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Haemonetics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HAE has been successfully added to your 